This week in drug discovery (11-15 July)

News round-up by DDW’s Reece Armstrong for 11 – 15 July.

Urgency a must for global fight against AMR, report says

Urgent access to vaccines that can fight and prevent infections, and curb the risk of antimicrobial resistance (AMR) is needed to save lives, according to a report by the World Health Organisation (WHO).

Could this drug help repair nerve damage?

Research from the University of Birmingham in the UK has indicated that a cancer therapy could help damaged nerves repair themselves following spinal injury.

First treatment for sickle cell side-effect in 20 years approved

The first new treatment in 20 years that prevents a common, painful side-effect in patients with sickle cell disorder (SCD) has been issued interim acceptance by the Scottish Medicines Consortium (SMC).

Awakn Life Sciences receives UK backing for ketamine therapy  

Biotechnology company Awakn Life Sciences has received funding from Innovate UK to help it advance its ketamine-assisted therapy programme to market in the UK and US.

BioLago’s ‘Science meets business’ event makes successful return 

After a two-year break, the cross-border health network BioLago’s in-person forum returned: ‘Science meets business’ took place 8 July 2022 at the University of Konstanz, Germany.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free